Prevention of neonatal late-onset sepsis associated with the removal of percutaneously inserted central venous catheters in preterm infants

Pediatric Critical Care Medicine

Volumn 12, Issue 4, 2011, Pages 445-448

  Hemels, Marieke A C ^a   Van Den Hoogen, Agnes ^a   Verboon Maciolek, Malgorzata A ^a   Fleer, André ^a,b   Krediet, Tannette G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

cefazolin; coagulase negative staphylococci; neonatal sepsis; percutaneously inserted central venous catheters; preterm infant

Indexed keywords

CEFAZOLIN;

ARTICLE; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DEVICE INFECTION; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; ONSET AGE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 79960842555     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182070f5d     Document Type: Article

References (21)

1. Fanaroff AA, Korones SB, Wright LL, et al: Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998; 17:593-598 (Pubitemid 28340869)
2. Stoll BJ, Gordon T, Korones SB, et al: Lateonsetsepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 63-71 (Pubitemid 26277248)
3. Stoll BJ, Hansen N, Fanaroff AA, et al: Lateonset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-291 (Pubitemid 34833012)
4. Makhoul IR, Sujov P, Smolkin T, et al: Pathogen- specific early mortality in very low birth weight infants with late-onset sepsis: A national survey. Clin Infect Dis 2005; 40: 218-224 (Pubitemid 40110664)
5. Adams-Chapman I, Stoll BJ: Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006; 19:290-297 (Pubitemid 43740369)
6. Kiechl-Kohlendorfer U, Ralser E, Pupp Peglow U, et al: Adverse neurodevelopmental outcome in preterm infants: Risk factor profiles for different gestational ages. Acta Paediatr 2009; 98:792-796
7. Streubel AH, Donohue PK, Aucott SW: The epidemiology of atypical chronic lung disease in extremely low birth weight infants. J Perinatol 2008; 28:141-148 (Pubitemid 351217642)
8. Golombek SG, Rohan AJ, Parvez B, et al: "Proactive" management of percutaneously inserted central catheters results in decreased incidence of infection in the ELBW population. J Perinatol 2002; 22:209-213 (Pubitemid 34461098)
9. Kacica MA, Horgan MJ, Ochoa L, et al: Prevention of gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr 1994; 125:253-258 (Pubitemid 24253011)
10. Spafford PS, Sinkin RA, Cox C, et al: Prevention of central venous catheter-related coagulase- negative staphylococcal sepsis in neonates. J Pediatr 1994; 125:259-263 (Pubitemid 24253012)
11. Barefield ES, Philips JB III: Vancomycin prophylaxis for coagulase-negative staphylococcal bacteremia. J Pediatr 1994; 125:230-232 (Pubitemid 24253004)
12. Elhassan NO, Stevens TP, Gigliotti F, et al: Vancomycin usage in central venous catheters in a neonatal intensive care unit. Pediatr Infect Dis J 2004; 23:201-206 (Pubitemid 38332642)
13. Krediet TG, Fleer A: Should we use vancomycin as prophylaxis to prevent neonatal nosocomial coagulase-negative staphylococcal septicaemia? Pediatr Infect Dis J 1998; 17:763-764 (Pubitemid 28388178)
14. Baier RJ, Bocchini JA Jr, Brown EG: Selective use of vancomycin to prevent coagulasenegative staphylococcal nosocomial bacteremia in high risk very low birth weight infants. Pediatr Infect Dis J 1998; 17:179-183 (Pubitemid 28146056)
15. van den Hoogen A, Brouwer MJ, Gerards LJ, et al: Removal of percutaneously inserted central venous catheters in neonates is associated with the occurrence of sepsis. Acta Paediatr 2008; 97:1250-1252
16. Palazzi DL, Klein JO, Baker CJ: Bacterial sepsis and meningitis. In: Infectious Diseases of the Fetus and Newborn Infant. Sixth Edition. Remington JS, Klein JO (Eds). Philadelphia, PA, Elsevier and Saunders, 2006, pp 247-295
17. Isaacs D, Australasian Study Group For Neonatal Infections: A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed 2003; 88: F89-F93 (Pubitemid 36269526)
18. Paisley JW, Lauer BA: Pediatric blood cultures. Clin Lab Med 1994; 14:17-30 (Pubitemid 24089818)
19. Krediet TG, Jones ME, Gerards LJ, et al: Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase- negative staphylococcal septicaemia in neonates: Relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics 1999; 103:E29
20. van den Hoogen A, Gerards LJ, Verboon- Maciolek MA, et al: Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 2010; 97:22-28
21. de Silva GD, Kantzanou M, Justice A, et al: The ica operon and biofilm production in coagulase-negative staphylococci associated with carriage and disease in a neonatal intensive care unit. J Clin Microbiol 2002; 40: 382-388 (Pubitemid 34130857)